
|Articles|January 1, 2003
Glaucoma drugs may pose risk to ocular surface
Author(s)Julia Talsma
Orlando-Ophthalmologists should be aware of the risks to the ocular surface associated with long-term use of glaucoma medications, according to Robert J. Noecker, MD, MBA, who also spoke at the Cornea Health symposium during the American Academy of Ophthalmology annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
UPDATE: STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
3
Topcon Healthcare seeks to advance company through acquisition and new investment
4
The future of glaucoma care: Where innovation meets everyday practice
5

















































.png)


